Clinical Professor of Medical Oncology, Thomas Jefferson University
Hematology
Dr. William J. Tester, MD
|
|
Give Review
William Tester practices Hematology. He graduated from Drexel University College of Medicine. He received 5 awards: "Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FACP)" and "Top MD". William J. Tester, MD is a published physician as well. He has 36 publications published. The latest was: Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain. He is registered with Medicare and accepts Medicare payments.
Publications
- Long-term outcomes in patients with muscle-invasive bladder Cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy...
- Report of a Phase I Evaluation of Dose and Schedule of Interleukin-1 Alpha and Cyclophosphamide in Patients with Advanced Tumors: An Eastern Cooperative Oncology Group...
- Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal Cancer.
- Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma.
- Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for ...
- Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patient...
- Inhibition of Renin Angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic Disease.
- Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance o...
- Use of a comprehensive survey as a first step in addressing clinical competence of physicians-in-training in the management of pain.
- The importance of patient participation in second-line chemotherapy decisions: perspectives of African-American patients.
- Infradiaphragmatic versus supradiaphragmatic Hodgkin Lymphoma: a retrospective review of 1,114 patients.
- Modifiable factors that influence colon Cancer lymph node sampling and examination.
- A 21-year-old male with dyspnea at rest, dry cough, and swelling of his right anterior chest.
- Pain management practices by internal medicine residents--a comparison before and after educational and institutional interventions.
- Rectal Hodgkin's disease in acquired immune deficiency syndrome.
- Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for Cancer pain.
- Treatment preferences and advance care planning at end of life: the role of ethnicity and spiritual coping in Cancer patients.
- Family care giving for patients at life''s end: report from the cultural variations study (CVAS).
- Reduced risk of bone metastasis for patients with breast Cancer who use COX-2 inhibitors.
- Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers.
- Phase I/II study of weekly docetaxel and vinblastine in the treatment of metastatic hormone-refractory prostate Carcinoma.
- Combined modality program with possible organ preservation for invasive Bladder carcinoma: results of RTOG protocol 85-12.
- Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with mu...
- Innovative treatments for non-small cell lung Cancer.
- Neoadjuvant combined modality program with selective organ preservation for invasive bladder Cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
- Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell Lung c...
- Overview of bladder Cancer trials in the Radiation Therapy Oncology Group.
- A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung Cancer: an Eastern Cooperative Oncology Gr...
- Phase II study of patients with metastatic nonsmall cell Carcinoma of the lung treated with paclitaxel by 3-hour infusion.
- Development of anemia and recovery in prostate Cancer patients treated with combined androgen blockade and radiotherapy.
- Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary Carcinoma: a phase I Eastern Cooperative Oncology...
- Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
- Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular Carcinoma and other solid tumors.
- "Salvage" radiation therapy for intrathoracic small cell Carcinoma of the lung progressing on combination chemotherapy.
- Successful rechallenge to etoposide after an Acute vasomotor response.
Schools
Drexel University College of Medicine
Albert Einstein Med Center
Georgetown University
National Cancer Institute
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FACP)
- Top MD
Education
-
Georgetown University Hospital -
National Institutes of Health Clinical Center -
Albert Einstein Healthcare Network -
Drexel University College of Medicine
Hospital
-
Einstein Medical Center Philadelphia
Drug Facts
| NPI NUMBER | 1386613693 | |
| NPPES Provider LastName | TESTER | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 19141 | |
| NPPES Provider State | PA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 892.0 | |
| Distinct Opioid Count | 7.0 | |
| Opioid Claim Count | 180.0 | |
| Percent Opioid Claims | 20.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386613693 |
| Last Name Of The Provider | TESTER |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Dr. Mary Ellen Martin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Tuveson, MD |
|
|
Dr. Anita J. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emmanuel T. Quien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas E. Guggenheim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ran Reshef, MD |
|
|
Dr. Jongming Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory L. Beatty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariusz A. Wasik, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Roland E. Knoblauch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean M. Kane, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger B. Cohen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David L. Porter, MD
This Doctor is OpenDoctor Recommended.
|